Author

P. Betancur

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Assay:ATAC-seq· 1 Approach:benchmark study· 1 Approach:biophysical modeling· 1

Frequent Co-Authors

C. Di Benedetto· 1 shared G. P. Nolan· 1 shared G. Valdes· 1 shared G. Wernig· 1 shared J. Oh· 1 shared J.-W. Lee· 1 shared L. Cui· 1 shared P. Domizi· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Di Benedetto

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NSMCE2, a Novel Super-Enhancer Regulated Gene, is Linked to Poor Prognosis and Therapy Resistance in Breast Cancer

C. Di Benedetto, J. Oh, Z. Choidhery, W. Shi, G. Valdes, P. Betancur

This study identifies NSMCE2 as a super-enhancer regulated gene linked to poor prognosis and therapy resistance in breast cancer, showing that targeting it can enhance chemotherapy effectiveness.

bioRxiv · Apr 1, 2022Cancer Biology

Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity

L. Cui, S.-Y. Chen, T. Lerbs, J.-W. Lee, P. Domizi, S. Gordon, Y.-h. Kim, G. P. Nolan, P. Betancur, G. Wernig

This study shows JUN activation in fibroblasts drives fibrosis and modulates immunity, with therapeutic potential through targeting IL-6, CD47, and PD-L1.

bioRxiv · Mar 18, 2020Immunology